Related Experiment Video
Updated: Jul 19, 2026

Gastric Point of Care Ultrasound in Adults: Image Acquisition and Interpretation
Published on: September 22, 2023
Does aspirin prolong bleeding from gastric biopsies in man?
Aspirin use does not prolong gastric bleeding time, making endoscopic gastric biopsy safe even after recent aspirin ingestion. This study found no increased bleeding risk from gastric biopsies in patients taking aspirin.
Area of Science:
- Gastroenterology
- Hematology
- Pharmacology
Background:
- Aspirin is known to prolong skin bleeding time by affecting platelet function.
- A potential increase in gastric bleeding time after aspirin use has been suggested as a cause of gastric hemorrhage.
- The safety of endoscopic gastric biopsy in patients taking aspirin remains a concern.
Purpose of the Study:
- To investigate the effect of acute and chronic aspirin use on gastric bleeding time.
- To determine if aspirin ingestion prolongs gastric bleeding time following endoscopic biopsy.
- To assess the safety of endoscopic gastric biopsy in patients on aspirin therapy.
Main Methods:
- Gastric bleeding time was directly assessed after endoscopic biopsy in four groups.
- Skin bleeding time was measured using the Mielke method.
- Study included control subjects, normal volunteers with acute aspirin (24 hours, two weeks), and patients with chronic aspirin use (rheumatoid arthritis).
Main Results:
- Aspirin ingestion did not significantly affect gastric bleeding time in normal volunteers, despite prolonged skin bleeding times.
- Gastric bleeding time was consistently shorter than skin bleeding time across all study groups.
- No increased gastric bleeding was observed in patients undergoing biopsy after aspirin use.
Conclusions:
- Aspirin ingestion does not prolong gastric bleeding time in humans.
- Endoscopic gastric biopsy is considered safe for patients, irrespective of recent aspirin ingestion.
- The findings suggest that recent aspirin use should not be a contraindication for gastric biopsy procedures.
More Related Videos
03:05Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
04:08Evaluation of the Effectiveness of Longitudinal Incision for Endoscopic Submucosal Excavation of Gastric Subepithelial Lesions
Published on: April 28, 2026
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...